September 23, 2012 marks Restless Legs Syndrome Awareness Day. This year, the RLS Foundation in the United States and Canada, the European Alliance for Restless Legs Syndrome (EARLS), the European Restless Legs Syndrome Study Group (EU-RLSSG), the International RLS Study Group (IRLSSG), and the World Association of Sleep Medicine (WASM) have joined forces to create an international coalition of individuals affected by the disease, and clinicians and neuroscientists dedicated to solving the mysteries of RLS/WED.
On September 23, 2012, these groups are coming together to recognize International Restless Legs Syndrome Awareness Day—a day dedicated to the continuation of educating the public and working together as we take steps towards to develop better treatments and, ultimately, a cure for RLS.
While there is currently no cure for RLS, there is effective treatment. Mild symptoms can often be successfully managed and controlled with lifestyle changes, such as increased exercise and better sleep hygiene.
For moderate and more severe cases of Restless Legs Syndrome, prescription medications can be helpful in managing the condition. In fact, in 2012, a ten-member task force from the International RLS Study Group released the “Summary of Recommendations for the Long-Term Treatment of RLS/WED.” The report outlined several classes of drugs that have been shown to be effective in the long-term treatment of RLS. These medications include dopamine agonists and alpha-2 delta ligands.
For more information on treatment guidelines—and a copy of the IRLSSG's “Summary of Recommendations for the Long-Term Treatment of RLS/WED” paper— visit irlssg.org. The full version of the press release can be viewed online at prnewswire.com/news-release...
Restless Legs Syndrome Awareness Day 2012 has been generously supported through an unrestricted educational grant from XenoPort.